Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • ACT Tulsa
  • Contact

Tetherex Pharmaceuticals is developing novel products to treat thrombosis inflamatory disease and cancer.  Its lead clinical program is focused on an antibody names SelK2 initally under development for the treat of venous thromboembolism and Crohn’s desease.

Year Founded: 2014

Year Partnered: 2014

Category: BioTech/Pharma

Fund: Angel Fund II, Accelerate, Oklahoma Seed Capital Fund  

www.tetherex.com

i2E-300dpi-Trans-Light
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
PHONE 405/235-2305
Click HERE for printable map with directions.

Tulsa Office

100 S. Cincinnati Ave – 5th Floor, Suite 514
Tulsa, OK 74103
PHONE 918/582-5592
Copyright 2022 i2E, Inc. | All Rights Reserved
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
    • ACT Tulsa
  • e3
  • Concept Fund
  • Portfolio
  • iMCI
  • ACT Tulsa
  • Contact
i2E